Dr. Li is a behavioral statistician with a joint appointment in the Department of Psychiatry & Behavioral Sciences and the Department of Epidemiology and Biostatistics. His expertise is in Bayesian Item Response Theory and Bayesian Multilevel Modeling. His current research focuses on Bayesian Nonparametric methods in psychology as well as Patient-Reported Outcomes data analysis using Machine Learning analytics, including Dirichlet Process Mixture Modeling (PMID: 31217637) on psychological symptom clusters for patients with advanced/terminal cancer near the end of life and Latent Dirichlet Allocation to score patients’ quality of life (PMID: 30798421). Clinicians are no longer restricted by conventional QOL surveys which rely on fixed (and often lengthy) surveys that routinely neglect each patient’s idiosyncratic goals and priorities. Patients’ goals can now be incorporated to enhance conventional data from fixed-length QOL measures. Dr. Li also works on making these revolutionary ideas accessible to behavioral scientists in his tutorials on Bayesian psychometric methods (PMID: 29424559, 22362655, 27193366).
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Yuelin Li discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2022 through disclosure submission in spring 2023). This data reflects interests that may or may not still exist. This data is updated annually.